Topics
16:00 – 16:20
Presentation
(Local Authorities, Organizing Comittee, SEC)
16:20 – 16:30
HYPERTROPHIC CARDIOMYOPATHY IN A CORUÑA:
HISTORIC OVERVIEW.
Lecture: Dr. William J. Mckenna (UK)
16:30 – 17:35
16:30 – 16:45
16:45 – 16:50
16:50 – 17:00
17:00 – 17:10
17:10 – 17:20
17:20 – 17:35
GENETIC BASIS OF HYPERTROPHIC
CARDIOMYOPATHY
Moderator: Dr. Connie Bezzina (The Netherlands)
New Frontiers: Gene therapy in Hypertrophic Cardiomyopathy.
Lecture: Dr. Hugh Watkins (UK)
Clinical case: Dr. Julián Palomino-Doza (Spain)
Expert 1: Classical Hypertrophic Cardiomyopathy genes.
Dr. Lorenzo Monserrat (Spain)
Expert 2: Polygenic risk scores.
Dr. James Ware (UK)
Expert 3: New genes? Oligogenic variants?
Dr. Juan P. Ochoa (Spain)
Panel Discussion: Speakers and Dr. Pablo García-Pavía (Spain)
17:35 – 18:15
Coffee break
18:15 – 19:00
MYOSIN INHIBITORS: ARE THEY THE PHILOSOPHERS’
STONE FOR HYPERTROPHIC CARDIOMYOPATHY?
Moderator: Dr. Perry Elliott (UK)
Myosin Inhibitors in obstructive HCM.
Lecture: Dr. Iacopo Olivotto (Italy)
Myosin Inhibitors in non-obstructive HCM.
Lecture: Ahmad Masri (USA)
Panel Discussion: Speakers and Dr. Roberto Barriales Villa (Spain)
19:00 – 19:55
CONTROVERSIES IN TREATMENT OF
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
Moderator: Dr. Maite Tomé (UK)
Clinical case: Dr. Juan Jiménez-Jaimez (Spain)
Expert 1: Is there a new role for betablockers?
Dr. Anne Dybro (Denmark)
Expert 2: Is there any role for myectomy?
Dr. Eduard Quintana (Spain)
Expert 3: Is septal alcohol ablation safe and effective?
Dr. Hubert Seggewiss (Germany)
Panel Discussion: Speakers and Dr. Juan Ramón Gimeno (Spain)
19:55 – 20:00
Conclusions
9:30 – 10:30
CONTROVERSIES IN HYPERTROPHIC
CARDIOMYOPATHY (I)
Moderators: Dr. Elena Arbelo (Spain) and Dr. Elena Biagini (Italy)
SCD Risk Stratification in HCM: state of the art/ controversies.
Lecture: Dr. Perry Elliott (UK)
Clinical case: Dr. José M. Larrañaga-Moreira (Spain)
Expert: Must we include genetics in SCD HCM risk-score?
Dr. Roberto Barriales Villa (Spain)
Clinical case: Dr. Eduardo Villacorta Argüelles (Spain)
Expert: Role of blood pressure response, LGE and apical aneurism.
Dr. Juan Ramón Gimeno (Spain)
Panel Discussion: Speakers and Dr. William J. Mckenna (UK)
10:30 – 11:15
CONTROVERSIES IN HYPERTROPHIC
CARDIOMYOPATHY (II)
Moderators: Dr. Elena Arbelo (Spain) and Dr. Elena Biagini (Italy)
Risk stratification in pediatric population
Clinical case: Dr. Mireya Castro Verdes (Spain)
Expert: Dr. Juan Pablo Kaski (UK)
Sports in HCM patients
Clinical case: Dr. José M. García Pinilla (Spain)
Expert: Dr. Shanjay Sharma (UK)
Panel Discussion: Speakers and Dr. Iacopo Olivotto (Italy)
11:15 – 12:00
Coffee break
12:00 – 12:30
12:00 – 12:15
12:15- 12:30
HYPERTROPHIC CARDIOMYOPATHY AND ITS MIMICS
Moderator: Dr. José Rodríguez Palomares (Spain)
Precision diagnostics for a precision therapy era.
Lecture: Dr. James Moon (UK)
Panel discussion: Speakers and Dr. William J. Mckenna (UK)
13:10 – 13:25
FABRY DISEASE
Moderator: Dr. Olga Azevedo (Portugal)
When to start treatment in woman?
Lecture: Dr. Grigorios Effraimidis (Denmark)
Clinical case. Dr. María Luisa Peña Peña (Spain)
Expert 1: Is LysoGB3 the solution for the diagnosis and the follow up?
Dr. Juan Politei (Argentina)
Expert 2: Role of MRI in the diagnosis.
Dr. Antonia Camporeale (Italy)
Panel discussion: Speakers and Dr. Tomás Ripoll Vera (Spain)
Lunch
15:00 – 15:55
CARDIAC TTR AMYLOIDOSIS
Moderators: Dr. Esther González López (Spain) and Dr. Tomás Ripoll Vera (Spain)
New treatments in cardiac ATTR.
Lecture: Dr. Pablo García-Pavía (Spain)
Clinical case: Dr. Gonzalo Barge Caballero (Spain)
Expert 1: Are DPD scintigraphy or cardiac MRI 100% specific for the diagnosis?
Dr. Stefano Perlini (Italy)
Expert 2: When to start treatment in TTR carriers?
Dr. Isabel Conceição (Portugal)
Panel discussion: Speakers and Dr. Ahmad Masri (USA)
15:55